SOX9 and familial pancreatic carcinoma: Moreover, the analysis of the available information from The Cancer Genome Atlas (TCGA) project associated high SOX9 expression with reduced overall survival (p = 0.011) (Figure 8E), showing the relevance of SOX9 in the clinical progression of pancreatic cancer.